Nvidia vs. AMD: The Better AI Chip Stock for 2026

AMD has outperformed Nvidia in 2026, with shares up 114% versus Nvidia's 18%, as AMD revenue rose 38% in Q1 to $10.25 billion and adjusted EPS increased 43% to $1.37. Nvidia remains stronger on scale, posting fiscal 2026 revenue of $215.9 billion, up 65%, and EPS of $4.77, with a $1 trillion order pipeline for 2026-2027. The article argues Nvidia is the better buy on valuation, citing a PEG of 0.68 versus AMD's 1.09 despite AMD's faster expected growth.

Analysis

The market is effectively pricing two different business models: AMD as a near-term share-gain story and NVDA as a compounding platform with a longer duration backlog. That matters because once a stock rerates on growth acceleration, the next leg usually depends on whether that growth is repeatable without margin dilution; AMD’s key test is not demand, but execution across supply allocation, software attach, and customer concentration into 2H26. If those AI deployments slip even one quarter, the valuation multiple can compress faster than earnings can catch up.

NVDA’s setup is less exciting on the surface but better for capital preservation: a lower multiple on still-elite growth typically wins when the AI trade broadens from “who has the most momentum” to “who can defend economics through the cycle.” The bigger second-order issue is that AMD’s success is partly dependent on proving that hyperscalers want a second-source strategy, not just lower price per compute; if that narrative hardens, it pressures pricing across the entire accelerator stack, including emerging challengers and adjacent networking vendors.

The market may be underweighting the timing mismatch between the two stories. AMD’s catalyst is back-half 2026, so the stock is vulnerable to any delay, while NVDA’s backlog supports estimates more immediately and gives management room to keep spending into physical AI and systems-level integration. In contrast, the consensus may be overconfident that AMD’s faster percentage growth automatically translates into superior stock performance from here; after a 100%+ run, the bar is now execution plus margin expansion, not just revenue upside.

The contrarian read is that the better trade is not outright chasing the highest-growth name, but owning the highest-quality growth at the cheaper implied expectation set. If AI capex remains robust, NVDA can still reaccelerate via ecosystem expansion, while AMD becomes the more crowded long and thus the one most exposed to disappointment. The asymmetry favors owning the lower-multiple incumbent and treating AMD as a tactical momentum name, not a core hold.

Key Decisions for Investors

• Long NVDA / short AMD pair trade for 3-6 months: express the view that the market is overpaying for AMD’s back-half execution while underpricing NVDA’s backlog-supported durability; target mean reversion in relative multiple with defined downside if AMD milestones slip.
• Add NVDA on pullbacks over the next 2-8 weeks: best risk/reward is entry into weakness, not strength, because backlog visibility should support estimate revisions even if the stock lags broader semis temporarily.
• Trade AMD tactically only: buy call spreads into confirmed 2H26 deployment checkpoints, but avoid outright long exposure through the next earnings cycle unless channel checks confirm delivery timing; reward is high if execution hits, but gap risk is asymmetric.
• Consider long META as an indirect beneficiary if AMD deployment timelines remain intact: the market may eventually view hyperscaler capex as more durable, but the trade should be sized smaller because the stocks are already linked and correlation can rise in selloffs.
• Use a hedge via SOXX/SMH downside puts against any concentrated long in AMD: semis can stay strong while single-name execution risk widens; this protects against a rotation from momentum to quality if AI spending sentiment cools.